(Q35142616)
Statements
1 reference
Fludarabine-melphalan conditioning for AML and MDS: alemtuzumab reduces acute and chronic GVHD without affecting long-term outcomes (English)
1 reference
Sergio Giralt
1 reference
Koen van Besien
1 reference
Rangesh Kunavakkam
1 reference
Gaby Rondon
1 reference
Marcos De Lima
1 reference
Andrew Artz
1 reference
Betul Oran
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference